From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA considers loosening naproxen's CV warning

from Medscape

Data published since 2006 suggest that naproxen does not pose the same cardiovascular risks as other nonsteroidal anti-inflammatory drugs, according to Food and Drug Administration reviewers. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063